Characteristics of non-valvular atrial fibrillation patients who benefit most from anticoagulation treatment.

Abstract

OBJECTIVES The objective was to determine who will benefit most from oral anticoagulation (OAC) for non-valvular atrial fibrillation (NVAF) patients aged ≥ 75 years. BACKGROUND It was unclear whether all of NVAF aged ≥ 75 should receive OAC. METHODS We recruited NVAF ≥ 75 years without QAC who were divided into three groups according to CHA2DS-VASc… (More)

Topics

4 Figures and Tables

Slides referencing similar topics